ArticleAnnals of translational medicine2022
Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer.
Mariya Rozenblit et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it